Literature DB >> 3262162

Partial purification and characterization of systemic lupus erythematosus derived factors that suppress production of interleukin-2.

M Linker-Israeli1, N Casteel.   

Abstract

We report here on interleukin-2 (IL-2) suppressive factors, synovial fluid (SF) peripheral blood mononuclear cells (PBM), derived from short term cultures of unstimulated PBM of patients with systemic lupus erythematosus (SLE). SF PBM suppressed production of IL-2, but not proliferative responses to this lymphokine. It was sensitive to acid (pH 2.6), heat (56 degrees C), and tryptic digestion. It retained activity in the presence of 2-mercaptoethanol (2-ME), had no interferon activity and no non-specific cytotoxicity. Although crude SF PBM contained IgG and PGE2, these were not associated with its 2 active fractions. SF PBM was partially purified on a G-200 Sephadex column. IL-2 suppressive activity was detected in 2 fractions of molecular weights corresponding to greater than 150 kD and 40-60 kD, the latter acting only in the presence of monocytes. SF PBM appear to affect directly the IL-2 producer cell, since it suppressed IL-2 production by (1) mitogen stimulated PBM depleted of CD8+ suppressor cells and by (2) mitogen induced Jurkat cells. These "spontaneous" suppressive factors were ubiquitous in SLE, and may be important tools for studying the defective IL-2 production in SLE and its significance in the development of the disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262162

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  2 in total

Review 1.  Human nonspecific suppressive lymphokines.

Authors:  M T Halpern
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

2.  Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.

Authors:  N J Struyf; H W Snoeck; C H Bridts; L S De Clerck; W J Stevens
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.